Recalls / Active ingredient / Posaconazole
Posaconazole
2 FDA drug recalls involving the active ingredient “Posaconazole”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-12-12 | Class II | Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, M | Merck Sharp & Dohme LLC |
| 2023-01-31 | Class II | Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., | BIOCON PHARMA INC |